openPR Logo
Press release

Neuromodulation Market will be Valued at US$ 5 Billion Globally by 2021 | Top Key Players – Medtronic, Boston Scientific, St. Jude Medical, LivaNova (Cyberonics), Nevro Corp

08-27-2018 09:49 AM CET | Health & Medicine

Press release from: Amigo Market Reports

Market Overview

The global neuromodulation market is poised to cross US$ 5 Billion mark by 2021. Neuromodulation is a technology that acts directly upon nerves. It is the alteration-or modulation-of nerve activity by delivering electrical or pharmaceutical agents directly to a target area. Neuromodulation devices and treatments are life changing.

Sample Report Available with Current Trends and Future Advancement @ https://www.amigomarketreports.com/sample-request/1815

They affect every area of the body and treat nearly every disease or symptom from headaches to tremors to spinal cord damage to urinary incontinence. With such a broad therapeutic scope, and significant ongoing improvements in biotechnology, the neuromodulation is poised as a major growth industry for the next decade. The market growth is attributed to factors such as an increased adoption of neuromodulation devices, ageing population, rising prevalence of diseases relevant to neuromodulation, technological advancements and deal making activity globally.

Top Player’s Analysis

Neuromodulation Market Company Analysis - Medtronic has been the dominant market player in the global neuromodulation market. However, it is facing increased competition from other players operating in the neuromodulation market. Boston Scientific is the second leading player for neuromodulation market in 2015. St. Jude Medical is the third largest player by market share in the overall neuromodulation market. While, LivaNova (Cyberonics) and Nevro Corp. stands at the fourth and fifth spot respectively in the global neuromodulation market space.

By Technology Neuromodulation Market Analysis - In terms of technology, Spinal cord stimulation (SCS) is the largest segment of the market and is mostly indicated for treatment of chronic pain. Deep brain stimulation (DBS) represents the second largest segment within the neuromodulation market being followed by Sacral nerve stimulation (SNS) at the third spot in 2015.

Get Discount on This Report @ https://www.amigomarketreports.com/discount-request/1815

By Applications Neuromodulation Market Analysis - In terms of applications, Chronic pain is the leading application segment of the neuromodulation market. The urinary and fecal incontinence market is the second largest application segment of the neuromodulation market. Refractory epilepsy holds third highest share of the neuromodulation market in 2015 being followed by Parkinson's disease. The Gastroparesis and Essential Tremor applications segment are competing closely with each other to grab maximum share of the pie.

Neuromodulation Market Regional Analysis - Geographically, North America is at the forefront of neuromodulation innovation, accounting for lion's share of the global neuromodulation market in 2015. Europe is the second leading region for neuromodulation market and it is likely to remain at this position throughout the forecasting period. Japan captured third highest share of the global neuromodulation market in 2015. While China and brazil are competing closely with each other to grab maximum share of the market. In Latin American countries, Mexico and Brazil represent significant market potential for neuromodulation manufacturers.

This 156 Page report with 63 Figures and 8 Tables has been analyzed from 7 viewpoints:

1. Global Neuromodulation Market and Forecast (2010 - 2021)
2. By Technology - Global Neuromodulation Market and Forecast (2010 - 2021)
3. By Applications Segment - Global Neuromodulation Market and Forecast (2010 - 2021)
4. Neuromodulation Market and Forecast - Regional Analysis (2010 - 2021)
5. Global Neuromodulation Market and Forecast - Company Analysis (2010 - 2021)
6. Global Neuromodulation Market - Major Deals
7. Global Neuromodulation Market - Driving Factors and Challenges

For More Information @ https://www.amigomarketreports.com/home/report_details/1815

About Us

We offer the exclusive market research solution for all the industries by performing the comprehensive investigation of industry trends, globally. The Association in every industry such as Technology, Healthcare, Aerospace, Consumable Goods and others demands a market-based solutions for various vital decisions based on productivity.

Our main goal is to Boost and Associate organizations to Build everlasting strategic enhancement and recognize growth Purpose. The organization assists its clients to accomplish business policies and achieve Continuous growth in their respective market domain.

Contact Us

Amigo Market Reports
USA Office
1507 Nolan St,
San Antonio, TX,78202
United States
Toll Free +1 (707) 925 3368
Email : sales@amigomarketreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuromodulation Market will be Valued at US$ 5 Billion Globally by 2021 | Top Key Players – Medtronic, Boston Scientific, St. Jude Medical, LivaNova (Cyberonics), Nevro Corp here

News-ID: 1200929 • Views:

More Releases from Amigo Market Reports

BREAST CANCER DRUG - GLOBAL MARKET OUTLOOK (2017-2026)
Global Breast Cancer Drug Market is accounted for $14.75 billion in 2017 and is expected to reach $43.27 billion by 2026 growing at a CAGR of 12.7% during the forecast period. High prevalence of breast cancer, growing R&D investments and rising healthcare expenditure and awareness are some of the key factors influence market growth. However, stringent regulatory guidelines and expiry of patented drugs is restraining the market growth. Breast cancer
Global Iris Recognition Market 2019 By Type and Application, Technological Breakthroughs and Industry Player’s like 3M Cogent Inc., Eyelock, Irisguard Inc., Honeywell International Inc., Delta ID Inc., Safran SA, Fulcrum Biometrics, LLC, Gemalto N.V., P
Global Iris Recognition Market 2019 By Type and Application, Technological Break …
Global Iris Recognition Market Highlights Global Iris Recognition market is accounted for $1972.68 million in 2017 and is expected to reach $11335.84 million by 2026 growing at a CAGR of 21.4% during the forecast period. Government and corporate activities to receive the iris acknowledgment framework in different fields and enlargement of e-passport program are some factors impacting the market growth. Request Sample Report @ https://www.amigomarketreports.com/sample-request/7238 Iris recognition is an imperative technique
Global Human Machine Interface (HMI) Market Developing Trends, Segments, Key Player’s - ABB Ltd, Honeywell International, Inc, Mitsubishi Electric Corporation, Schneider Electric Se, Siemens AG, General Electric Co, Kontron AG, Advantech Co., Ltd., Emer
Global Human Machine Interface (HMI) Market Developing Trends, Segments, Key Pla …
Global Human Machine Interface (HMI) Market Highlights Global Human Machine Interface (HMI) market is accounted for $3.86 billion in 2017 and is expected to reach $8.95 billion by 2026 growing at a CAGR of 9.8%. The rising need for efficiency and monitoring in the manufacturing plant and the evolution of industrial internet of things (II0T) & growing demand for smart automation solution are some of the key factors propelling market growth.
Global Hydrogen Fuel Cell Vehicle Market- Trends, Outlook with Top Industry Player’s Like- Daimler, Honda, Hyundai, Toyota, Audi, Ballard Power Systems, BMW, Fuel Cell Energy, GM Forecast 2019 to 2025
Global Hydrogen Fuel Cell Vehicle Market- Trends, Outlook with Top Industry Play …
Global Hydrogen Fuel Cell Vehicle Market Highlights Global Hydrogen Fuel Cell Vehicle Market valued approximately USD 465.0 million in 2017 is anticipated to grow with a healthy growth rate of more than 70.13% over the forecast period 2018-2025. The Hydrogen Fuel Cell Vehicle Market is continuously growing in the global scenario at significant pace. Hydrogen fuel cell vehicles (HFCVs) are a class of electric vehicles that power the drive train of

All 5 Releases


More Releases for Neuromodulation

Internal Neuromodulation Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Internal Neuromodulation market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This report is
Neuromodulation Devices Market 2022 | Detailed Report
The Neuromodulation Devices research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,
Neuromodulation Market Overview and Industry Outlook 2020
Global Neuromodulation Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Neuromodulation Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected
Neuromodulation Market Thriving Worldwide $11,717 Million By 2022
The global neuromodulation market size is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. The global neuromodulation devices market is estimated to reach $11,717 million by 2022. For More Info, Get PDF Sample : http://bit.ly/2BciOaa Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease affect the central and peripheral nervous system. Bacterial, viral, and fungal infections
Global Neuromodulation Devices Market 2027: Comprehensive Report Study
Market Research Future published a research report on “Global Neuromodulation Devices Market Research Report- Forecast To 2027” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027. Global neuromodulation devices market Information, by types by Techniques Applications - Forecast to 2027 Globally the market for neuromodulation devices is increasing rapidly. The major factor that derives the growth of neuromodulation devices is the increasing development neuromodulation devices. Furthermore increasing demand
Sacral Neuromodulation Systems Market Outlook to 2025
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities. According to a study on neuromodulation devices and therapies, neuromodulation is a safe, effective, and long term treatment for chronic pain and movement disorders. Neuromodulation technology is gaining momentum